The cell and gene therapy CDMO services market happened to be valued at $5193.7 million last year and is now anticipated to grow at a CAGR of 17.5% across the forecast period of 2023 to 2029.
- Elements driving the growth cell and gene therapy CDMO market
- Bloating pipeline when it comes to cell as well as gene therapy patients or candidates
- Rise in the embrace of treatments that look promising.
- Surge in investment in cell and gene therapy.
- Elevating trends concerning outsourcing.
- Advancement when it comes to manufacturing tech.
- Amicable regulatory environment.
It is well to be noted that the main drivers when it comes to the worldwide cell as well as gene therapy CDMO market include the rising prevalence of chronic diseases ranging from cardiac issues, genetic disorders, cancer, as well as auto-immune diseases all throughout the planet. Apparently, CAGT happens to have the potential to address the root cause in cases of genetic and acquired diseases and helps with concepts as well as techniques that can be made use of in the reproductive potential as well as remodelling and regulation of the gene.
Besides, the rise in application of gene therapy when it comes to diagnostic, drug discovery, therapeutic, and research pertaining to oncology as well as other clinical disorders in the US is leading to an increase in the number of geriatric patients and thereby elevating the incidences in terms of infectious diseases across the world and hence boosting the growth when it comes to the cell and gene therapy CDMO services segment.
Apart from this, rising spending on healthcare infrastructure establishments is expected to have a positive effect on market growth throughout the forecast period.
Furthermore, elevating investments when it comes to the launch of new products as well as clinical trials by the market players is anticipated to uplift the growth of the cell and gene therapy CDMO service market.
The elevating demand from the CDMOs from emerging pharma as well as biotech companies has further pushed the demand for market growth. The elevating trend of outsourcing manufacturing activities as well as the wide advantages of CDMOs are anticipated to offer profitable opportunities in cell and gene therapy CDMO market advancement.
The service market for CDMOs
Depending on the therapy type, the overall global cell and gene therapy CDMO services market is segregated into cell therapy and gene therapy. It is well to be noted that the cell segment is anticipated to comprise a larger revenue share across the worldwide cell and gene therapy CDMO services market. Apparently, cell therapy happens to be excessively used across clinical investigation in terms of cardiovascular diseases owing to pre-clinical studies of cell biology, mechanisms in terms of action, immunology, and phenotypic efficacy.
That said, allogenic therapy leads to great cell functionality and is readily available for research. Hence, these elements are anticipated to drive growth in terms of the cell and gene services market, which is segregated on the basis of type of therapy, its application, therapeutic area, end user, and topography.
Significantly, based on the kind of therapy, the market happens to be divided into:
- Cell Therapy
- Gene Therapy
When we take into account the application, the market can be segmented into:
- Clinical Manufacturing
- Commercial Manufacturing
Considering the therapeutic area, the market gets divided into:
- Orthopaedics
- Oncology
- Infectious diseases
- Cardiovascular illness and
- Others
Based on the end user, the market happens to be segmented into:
- Pharma & Biotechnology Firms
- Research as well as academic institutes and
- Others
Notably, strategic new product launches, M&As, as well as agreements happen to be pivotal strategies embraced by market players.
The worldwide cell and gene therapy CDMO services market further puts forth the fact that the major players are increasingly embracing strategies like the launch of newer product versions, the launch of products, and long-term alliances so as to enhance the market revenue share and also gain an all-important geographic presence throughout the region.
